Association of vitamin D receptor gene polymorphisms with breast cancer risk

J Cancer Res Ther. 2023 Jan 1;19(Suppl 2):S677-S681. doi: 10.4103/jcrt.jcrt_60_22. Epub 2023 Apr 30.

Abstract

Background: Recent literature suggests that vitamin D signaling has a protective effect against breast cancer risk. Thus, the aim of the present study was to find the association of vitamin D receptor (VDR) gene polymorphisms with breast cancer risk.

Materials and methods: Fok1, Bsm1, Apa1, and Taq1 polymorphisms were performed by polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP) method, and Poly A polymorphism was carried out using PCR-SSCP in 140 breast cancer patients and 155 controls.

Results: Odds ratio was significantly higher in both homozygous variant genotypes (LL) of Poly A polymorphism of VDR (odds ratio [OR] = 5.42, 95% confidence interval [CI] = 1.19-23.31, P = 0.02) and heterozygous variant genotypes (SL) of Poly A polymorphism of VDR (OR = 3.89, 95% CI = 1.10-13.7, P = 0.03). Fok1, Bsm1, Apa1, and Taq1 polymorphisms of VDR gene were not significantly associated with breast cancer risk.

Conclusion: Poly A polymorphism at the 3' untranslated region (UTR) of VDR gene was significantly associated with breast cancer risk in West Indian population.

MeSH terms

  • Breast Neoplasms* / epidemiology
  • Breast Neoplasms* / genetics
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Poly A
  • Polymorphism, Genetic
  • Receptors, Calcitriol / genetics
  • Vitamin D

Substances

  • Poly A
  • Receptors, Calcitriol
  • Vitamin D
  • VDR protein, human